Poster 20board3
Poster 20board5

Cytotheryx, Inc.

Cytotheryx is a biomedical research company focused on the development of human hepatocytes for use in research and therapeutic development

  • Stage Product In Development
  • Industry Biotechnology
  • Location Rochester, MN, USA
  • Currency USD
  • Founded February 2019
  • Employees 9
  • Incorporation Type C-corp
  • Website cytotheryx.com

Company Summary

Cytotheryx is a new start up biomedical research company founded by Exemplar Genetics and the Mayo Clinic focused on the development of human hepatocytes (HHCs) for use in research and therapeutic development. Initially targeting the research grade market for HHCs, Cytotheryx will quickly enter the liver assist, gene and cell therapy fields as it grows.

Team

  • John R. Swart, Ph.D. is the CEO of Cytotheryx and previously served as President and CEO of Exemplar Genetics. Dr. Swart has over 20 years of experience in the biomedical research industry with a focus on business development and operations management. At Cytotheryx, Dr. Swart will manage the formation and business operations.

  • Default avatar
    Joseph Lillegard, MD, PhD
    CSO

    Joseph B. Lillegard, MD, Ph.D. is a co-inventor on the patent and serves as a pediatric surgeon at Children's Minnesota and the Director of Research at the Midwest Fetal Care Center. His laboratory at Mayo Clinic conducts basic research related to cell and gene correction therapies in hepatocytes. Dr. Lillegard will serve as the chief scientific officer at Cytotheryx

  • Robert A. Kaiser, Ph.D., D.A.B.T will serve as Chief Operations Officer for Cytotheryx, overseeing the daily activities including research and development, and production. Dr. Kaiser has over 11 years of GLP research experience directing IND-enabling studies for experimental therapeutics

  • Ron Fedders is the CFO for Exemplar Genetics and brings over 20 years of experience to financial planning within the biotechnology industry.